Seven diseases are now known to be caused by expansions of triplet repeats. Four, including the subject of the present proposal, are caused by expansions of CAG repeats, coding for polyglutamine. These include Huntington's disease (HD), spinocerebellar ataxia type 1 (SCA-1), and spinal and bulbar muscular atrophy. All involve degeneration of differing, although overlapping, subsets of neurons. The most recently discovered CAG triplet repeat disease is dentatorubral and pallidoluysian atrophy (DRPLA or Smith's disease). The gene causing this disorder was identified as part of a screening program for triplet repeats in the principal investigator's laboratory (Li et al., 1993). Primer sequences published in our paper were used by two groups of Japanese investigators to demonstrate that triplet repeat expansion at this locus causes DRPLA. We now propose to clone the full length cDNA for this gene, which we are terming """"""""Atrophin-1."""""""" We have found that it has an unusual alternating acidic and basic residue protein motif with homology to other proteins, which may shed light on its function. We will clone and sequence full length cDNAs for rat and human versions of the cDNA. We will study the expression of the Atrophin-1 mRNA in human and rat tissues, in development, and in tissues from patients with the disorder, using techniques of RNA blot analysis and in situ hybridization. Based on the predicted protein sequence, we will synthesize unique peptides, couple them to carrier proteins, and raise and affinity purify specific antibodies. We will use these for protein blot and immunohistochemical studies to define the cellular and tissue localization of the Atrophin-1 protein. These studies will be carried out in parallel with ongoing studies in the PI's lab of the HD gene product. Together these studies should shed light on genes involved in these neurodegenerative disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
3R01NS034172-03S1
Application #
6012566
Study Section
Neurology C Study Section (NEUC)
Program Officer
Oliver, Eugene J
Project Start
1995-05-01
Project End
1999-02-28
Budget Start
1997-03-01
Budget End
1999-02-28
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Sawa, Akira; Nagata, Eiichiro; Sutcliffe, Siobhan et al. (2005) Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts. Neurobiol Dis 20:267-74
Nagata, Eiichiro; Sawa, Akira; Ross, Christopher A et al. (2004) Autophagosome-like vacuole formation in Huntington's disease lymphoblasts. Neuroreport 15:1325-8
Ross, Christopher A; Poirier, Michelle A (2004) Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl:S10-7
Igarashi, Shuichi; Morita, Hokuto; Bennett, Kyla M et al. (2003) Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation. Neuroreport 14:565-8
Ozeki, Yuji; Tomoda, Toshifumi; Kleiderlein, John et al. (2003) Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci U S A 100:289-94
Nucifora Jr, Frederick C; Ellerby, Lisa M; Wellington, Cheryl L et al. (2003) Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity. J Biol Chem 278:13047-55
Wheeler, Vanessa C; Gutekunst, Claire-Anne; Vrbanac, Vladimir et al. (2002) Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum Mol Genet 11:633-40
Luthi-Carter, Ruth; Strand, Andrew D; Hanson, Sarah A et al. (2002) Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum Mol Genet 11:1927-37
Peters, M F; Ross, C A (2001) Isolation of a 40-kDa Huntingtin-associated protein. J Biol Chem 276:3188-94
Nucifora Jr, F C; Sasaki, M; Peters, M F et al. (2001) Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291:2423-8

Showing the most recent 10 out of 26 publications